Trials / Completed
CompletedNCT02580032
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 252 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 4 Years – 13 Years
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Europe and the United States of America (USA). The aim of the study is to validate two measures for growth hormone deficiency in children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No treatment given. |
Timeline
- Start date
- 2015-10-05
- Primary completion
- 2018-05-14
- Completion
- 2018-05-14
- First posted
- 2015-10-20
- Last updated
- 2020-09-25
Locations
28 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT02580032. Inclusion in this directory is not an endorsement.